Life Technologies to Distribute Quidel MDx Assays | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will distribute and sell Quidel's molecular diagnostic assays in Europe under an agreement announced today.

Beginning next month, Life Tech will begin selling two Quidel molecular diagnostic tests — the Influenza A+B Real-Time RT-PCR Assay and the human metapneumovirus (hMPV) assays. Quidel had announced yesterday that its hMPV test had received the CE Mark. Its influzenza test received the CE Mark in August.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.